FDA Approved: RISEDRONATE SODIUM — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s original ANDA for generic risedronate sodium (RISEDRONATE SODIUM), authorizing its marketing in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis
• Osteoporosis in Men
• Paget Disease of Bone
• Postmenopausal Osteoporosis

Drugs mentioned

• RISEDRONATE SODIUM (RISEDRONATE SODIUM)

Snippet

ORIG AP for RISEDRONATE SODIUM (RISEDRONATE SODIUM)